If this page doesn't display properly in your email, Click here

February 1, 2008


Meeting on Key Issues in TB Drug Development

...Read Full Article



CDC Survey Shows Less Effective Flu Medications Still Used

...Read Full Article



EIN: Decolonize MRSA Patients or Not?

...Read Full Article



Health Alerts, Drug Approvals, Recalls, Adverse Events

...Read Full Article



In the IDSA Journals

...Read Full Article



Multidrug-resistant Staph Reported among MSM

...Read Full Article



CMS Requires NPI on Claims Starting March 1

...Read Full Article



Europe Reports High Percentage of Oseltamivir-resistant Influenza Virus

...Read Full Article



IDSA Policy & Advocacy Update IDSA Opposes Anti-Thimerosal Legislation

...Read Full Article



Welcome, New IDSA Members!

...Read Full Article

Meeting on Key Issues in TB Drug Development
CDC Survey Shows Less Effective Flu Medications Still Used
EIN: Decolonize MRSA Patients or Not?
Health Alerts, Drug Approvals, Recalls, Adverse Events
In the IDSA Journals
Multidrug-resistant Staph Reported among MSM
CMS Requires NPI on Claims Starting March 1
Europe Reports High Percentage of Oseltamivir-resistant Influenza Virus
IDSA Policy & Advocacy Update
Welcome, New IDSA Members!
Search Back Issues
Forward this Issue
Print-Friendly Version
Unsubscribe

Copyright IDSA 2008 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org

To ensure delivery of IDSA News please add idsanews@idsociety.org to your email address book or Safe Sender List. If you are still having
problems receiving our communications, see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm

Home Page Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA